A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)
Clinical trial NCT00889382 · COMPLETED
Trial details
- NCT number
- NCT00889382
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-05
- Primary completion
- 2014-08-01
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.